Tenoxicam

This classification denotes a nonsteroidal antiinflammatory drug, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z1R9N0A399. European Medicines Agency schedules Tenoxicam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10900MIG. Tenoxicam generally arises in the molecular formula C13H11N3O4S2. The term TENOXICAM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, no. 5 1981, list 21.) TENOXICAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tenoxicam under HS 29349990 and SITC 51579. As of Q4 2014, TENOXICAM remains the US FDA Preferred Term for this commodity. Tenoxicam bears US NLM identifiers UMLS ID C0076096 and NCI Concept Code C73097. SMILES: S1(=O)(=O)N(/C(=C(/O)NC2NCCCC2)C(=O)C2SCCC12)C.